Buradasınız

Anasayfa » Content

Periton Diyalizi Hastasında Nadir Bir Peritonit Etkeni: Streptococcus Agalactiae

A Rare Cause of Peritonitis in Peritoneal Dialysis Patient: Streptococcus Agalactiae

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2012
DOI: 
DOI 10.5262/tndt.2012.1003.20

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Peritonitis is a common clinical problem in patients treated by peritoneal dialysis. The most common organisms causing peritonitis are Gram-positive (especially staphylococcus species). Peritonitis with Streptococcus agalactiae causes rare but often fatal infections in peritoneal dialysis patients. We present the case of a 39-year-old female peritoneal dialysis patient who had peritonitis due to Streptococcus agalactiae and the infection was successfully treated with intraperitoneal Cefazolin and Vancomycin. There were no further episodes of peritonitis during the six-month follow-up.
Bookmark/Search this post with
Abstract (Original Language): 
Peritonit, periton diyalizi hastalarında sık karşılaşılan önemli bir problemdir. Olguların çoğunluğunda etken Gram pozitif mikroorganizmalardan Stafi lokoklardır. Streptococcus agalactiae peritoniti nadir görülen ancak fatal seyreden bir enfeksiyondur. Biz burada 39 yaşındaki kadın periton diyalizi hastasında Streptococcus agalactiae’ya bağlı gelişen peritoniti intraperitoneal Sefazolin ve Vankomisin tedavisiyle başarılı bir şekilde tedavi ettik. Hastanın izlemindeki 6 aylık süre içerisinde peritonit atağı gözlenmedi.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_21_pp_304-306.pdf
  • 3
304-306
  • Turkish

REFERENCES

References: 

1. Nessim SJ: Prevention of peritoneal dialysis-related infections.
Semin Nephrol 2011; 31: 199-212
2. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes
C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP,
Ramos A, Schaefer F, Uttley L; ISPD Ad Hoc Advisory Committee:
Peritoneal dialysis-related infections recommendations: 2005
update. Perit Dial Int 2005; 25: 107-131
3. Quintanar Lartundo JA, Palomar R, Dominguez-Diez A, Salas
C, Ruiz-Criado J, Rodrigo E, Martinez De Francisco AL, Arias
M: Microbiological profi le of peritoneal dialysis peritonitis and
predictors of hospitalization. Adv Perit Dial 2011; 27: 38-42
4. de Los Santos CA, Prado Lima Figueiredo AE, Poli-de-Figueiredo
CE: Streptococcus agalactiae: A rare peritoneal infection in a
continuous ambulatory peritoneal dialysis patient. Ren Fail 2010;
32: 1123-1124
5. Schröder CH, de Jong MC, Monnens LA: Group B streptococcus:
An unusual cause of severe peritonitis in young children treated
with continuous ambulatory peritoneal dialysis. Am J Kidney Dis
1991; 17: 231-232
6. Borra SI, Chandarana J, Kleinfeld M: Fatal peritonitis due to group
B beta-hemolytic streptococcus in a patient receiving chronic
ambulatory peritoneal dialysis. Am J Kidney Dis 1992; 19: 375-377
7. Yinnon AM, Jain V, Magnussen CR: Group B Streptococcus
(agalactiae) peritonitis and bacteremia associated with CAPD. Perit
Dial Int 1993; 13: 241
8. Winn HN: Group B streptococcus infection in pregnancy. Clin
Perinatol 2007; 34: 387-392
9. Larsen JW, Sever JL: Group B Streptococcus and pregnancy: A
review. Am J Obstet Gynecol 2008; 198: 440-448
10. Schröder CH, Bakkeren JA, Weemaes CM, Monnens LA: IgG2
defi ciency in young children treated with continuous ambulatory
peritoneal dialysis (CAPD). Perit Dial Int 1989; 9: 261-265

Thank you for copying data from http://www.arastirmax.com